PureCircle Limited : FY14–Audited Full Year Results · 10/09/2014 · - FY14 was an important...

PureCircle Limited : FY14– Audited Full Year ResultsAnalyst Call - 10 September 2014

PureCircle - Investor Slides - All rights reserved September 20141

Disclaimer• This document, which is personal to the recipient and has been issued by PureCircle Limited (the “Company”), comprises written materials/slides

for presentations to be held in September & October 2014. This document does not constitute or form part of any offer or invitation to sell or issue, or any solicitation of any offer to purchase or subscribe for, any shares in the Company, nor shall any part of it nor the fact of its distribution form part of or be relied on in connection with any contract or investment decision relating thereto, nor does it constitute a recommendation regarding the securities of the Company.

• This document has not been verified, does not purport to contain all information that a prospective investor may require and is subject to updating, revision and amending. The information and opinions contained in this document are provided as at the date of this presentation and are subject to change without notice. In furnishing this document, the Company does not undertake or agree to any obligation to provide the attendees with access to any additional information or to update this document or to correct any inaccuracies in, or omissions from, this document that may become apparent.

• No reliance may be placed for any purposes whatsoever on the information or opinions contained in this document or on its completeness. No representation or warranty, express or implied, is given by or on behalf of the Company its directors, officers or employees or any other person as to the accuracy or completeness of the information or opinions contained in this document and no liability whatsoever is accepted by the Company or any of its members, directors, officers or employees nor any other person for any loss howsoever arising, directly or indirectly, from any use of such information or opinions or otherwise arising in connection therewith.

• This document and its contents are confidential and may not be reproduced, redistributed or passed on, directly or indirectly, to any other person or published, in whole or in part, for any purpose. This presentation is for information purposes only and is directed only at, in the United Kingdom, qualified investors who are persons who (i) have professional experience in matters relating to investments falling within Article 19(1) of the Financial Services and Markets Act 2000 (Financial Promotion) Order 2005 (the “Order"); (ii) are persons falling within Article 49(2)(a) to (d) ("high net worth companies, unincorporated associations, etc") of the Order; or (iii) are persons to whom it may otherwise be lawfully communicated (all such persons together being referred to as "Relevant Persons"). By attending the presentation to which this document relates or by accepting this document, you will be take to have represented, warranted and undertaken that you are a Relevant Person.

• Certain statements, beliefs and opinions in this document, are forward-looking, which reflect the Company’s or, as appropriate, the Company’s directors’ current expectations and projections about future events. By their nature, forward-looking statements involve a number of risks, uncertainties and assumptions that could cause actual results or events to differ materially from those expressed or implied by the forward-looking statements. These risks, uncertainties and assumptions could adversely affect the outcome and financial effects of the plans and events described herein. Forward-looking statements contained in this document regarding past trends or activities should not be taken as a representation that such trends or activities will continue in the future. The Company does not undertake any obligation to update or revise any forward-looking statements, whether as a result of new information, future events or otherwise. You should not place undue reliance on forward-looking statements, which speak only as of the date of this document.

• By attending the telephone call presentation to which this document relates or by accepting this document in any other way you agree to be bound by the foregoing provisions.


Content1. CEO Overview Magomet Malsagov, CEO

2. Financial Review William Mitchell, CFO

3. Operational Review Jordi Ferre, COO

4. Outlook Magomet Malsagov, CEO

5. Questions


4

1. CEO Overview


by Magomet Malsagov, CEO

4

CEO Overview (1)Business Model - FY14 confirmed the operational gearing of our business model

- Our $31m sales growth led to $14m EBITDA and $12m net profit improvement- Across the combined period FY13 & FY14, we have grown sales $56m a year andimproved net profit $25m a year

Sales - Our sales increased $31m to $101m: (44% growth)- Volume gains were led by Stevia 3.0TM portfolio: we now have 12 products in market- The whole portfolio showed growth notably new innovations- All sales regions grew compared to FY13- Growing use of proprietary blends of our products by customers was a feature of FY14

Margins - FY14 gross margin was $37m, an increase of $18m (106%)- Gross margin % was up 11 points to 36%, we would expect further increases on higher sales

Inventories - FY14 inventories of $86m were flat against FY13- Includes finished goods production of new innovations ahead of expected sales growth

Debt & funding - FY14 net debt was $80m (FY13: $75m)- We have renewed and extended for 5 years our core $71m bank facility

Headroom - Our funding headroom is $60m and is sufficient for our current expansion plans


CEO Overview (2)

Market - Market adoption has accelerated across all Food and Beveragecategories- The scale and breadth of adoption is strong evidence of Stevia becominga mainstream ingredient- Adoption is being enabled by our Stevia 3.0TM portfolio

Carbonated Soft Drinks - FY14 was an important year for development of stevia in the key CSDcategory- Coca Cola Life, Pepsi Next, Sprite and other important global brandsannounced expanded roll-outs into larger markets

Regulatory - Currently over 4 billion consumers have access to stevia- Stevia clearances in India is imminent and will add an additional 1 billionconsumers- FDA GRAS approval for Reb M, a new zero-calorie sweetener jointlydeveloped with The Coca-Cola Company is an important milestone for us


CEO Overview (3)PureCircle Innovation - We launched 6 new products to market in FY14.

- Each innovation helps F&B brands find the right customized solution for their formulation.

Formulation & - We opened additional formulation & application laboratories in Technical support Mexico and Malaysia to support LATAM and SE Asia markets.

Stevia advocacy - The Global Stevia Institute (www.globalsteviainstitute.com) enhanced stakeholder engagement partnering with key customers to tailor advocacy for product launches. - The GSI reaches over 6,000 health professionals regularly.

Supply Chain - We delivered increased sales volumes across wider product portfolio to a wider range of delivery points than before. - At same time we scaled up production of new innovations and reduced unit costs of production.

Management - The Group further strengthened its senior management team with appointments of COO and other key new hires in Leaf Supply, Quality Control, Operational Finance and Human Resources.


http://www.globalsteviainstitute.com


2. Financial Review

by William Mitchell, CFO

USD’ m (FY13 restated) FY14 FY13 ChangeSales 101.0 70.2 +44%Gross margin 36.6 17.8 +106%

Operating profit 17.2 1.0 +16.2mEBITDA 22.9 9.1 +13.8mNet profit/(loss) after tax 2.3 (9.4) +11.7m

Operating cashflow before financing 15.5 (9.6) +25.1m

Net debt (79.9) (75.2) (4.7m)Net assets 147.5 141.8 +5.7mNet assets per share (U$ cents) 0.90 0.86 +0.04

Summary Financials


• FY14 confirmed the operational gearing of our business model - $31m sales growth led to $13m (152%) increase in EBITDA.

• $25m improvement in operating cashflow before financing• Principal bank facility renewed and extended for 5 years

Profit and Loss Account


USD’ m (FY13 restated) FY14 FY13 ChangeRevenue 101.0 70.2 +44%Cost of sales (64.4) (52.4) +106%

Gross margin 36.6 17.8 +18.8mGross margin % 36% 25% +11 points

Other income 0.4 0.4 -

Administrative expenses (19.8) (17.3) (2.5m)

Operating profit 17.2 1.0 +16.2m

Other expenses (6.1) (3.9) (2.2m)

Foreign exchange gain 1.3 2.4 (1.1m)

Finance costs (9.3) (8.4) (0.9m)

Share of loss in joint ventures (0.5) (0.3) (0.2m)

Taxation (0.3) (0.1) (0.2m)

Profit/(Loss) for the financial year 2.3 (9.4) +11.7m

EBITDA 22.9 9.1 +13.8m

Sales: - $31m (44%) increase. 37% volume and 5% pricing- Volumes: wider adoption, new innovations. - Pricing: sales mix more Stevia 3.0TM portfolio less co-products

Gross margin: - $36.6m, $18m increase (106%): - Improved sales volumes, sales mix and lower unit costs. - At 36% FY14 gross margin up 11% points vs FY13 25%. - Further improvement in gross margin expected as sales increase

Operating profit - $17m and $23m respectivelyand EBITDA: - Highly geared operational business model

- Sales increases lead to higher profitability - Sales up $31m, operating profit up $16m, EBITDA up $14m (152%) at $23m.

Share of loss of - New IFRS: JVs now equity accounted for (not proportional consolidation) Joint Ventures: - Loss up $0.2m reflecting increased investment in application support.

Finance costs: - Up $1m to $9m- Higher average FY14 net debt balance reflecting the FY13 decision to build inventories of Stevia 3.0TM products ahead of anticipated sales growth in FY14 and FY15.

Net profit after tax: - $2m net profit. $12m improvement.- Reflects EBITDA up $14m, $1m higher interest and $1m lower forex gain.

Profit and Loss Account


Operating cashflow: - $25m improvement : Stronger EBITDA and flat inventory- Further improvements expected as sales increase.- Payables down $3m –reflects flat inventories

Financing Activities: - FY13 includes $31m equity placing and $23m bank drawdowns for production

- FY14 reflecting flatter working capital- Post June 14: - $34m gross debt repayments

- $71m principal bank facility renewed and extended for 5 years

Cashflow


USD’ m (FY13 restated) FY14 FY13 ChangeOperating cashflow before working capital changes 22.7 6.8 +15.9m

- Inventories 0.1 (20.6) +20.7m- Receivables (4.4) (6.9) +2.5m- Payables (2.9) 9.7 (12.6m)

Operating cashflow 15.5 (9.6) +25.1m- Interest / tax (10.2) (8.2) (2.0m)- Capex / investments (11.4) (10.6) (0.8m)

Net cash from Financing (2.3) 52.4 (54.7m)Net movement in cash (8.4) 24.0 (32.4m)

• Production capacity fully invested that can support $250-300m+ of sales• Innovation investment accelerating: driving adoption of stevia and PCL market share• Inventory volumes have been sustained in anticipation of higher future sales growth

Balance Sheet


USD’ m (FY13 restated) FY14 FY13Intangible Assets 38.0 32.3

Working capital items:

- Inventory 86.5 86.5

- Receivables - excluding Joint Ventures 34.6 29.8

- Payables 18.7 20.8

Gross assets 292.8 287.6

Net debt (80.0) (75.2)

Net assets 147.5 141.8


3. Operational Review

by Jordi Ferre, COO

• Sales Performance:– FY14 sales increased $31m (44%) to $101m.– Volumes increased 37% led new value added ingredients from our Stevia 3.0 TM portfolio.– Continued reduction in lower value co-product sales in line with focusing on our Stevia 3.0 TM portfolio.

• Development of stevia as a mainstream ingredient in the Carbonated Soft Drink category:– The Coca Cola Company announced roll out of Coca-Cola Life into the USA, Mexico, UK, Sweden while PepsiCo extended Pepsi

Next into Canada, Finland and Netherlands.– Innovation in non-cola CSDs: Dr Pepper has launched a range of products with stevia in the USA.– Reformulation of Global Brands such as Sprite and Fanta continues in markets in Europe, Latin America and Asia.– Numerous other Carbonated Soft Drink are ready in development pipelines for launch.

• Favorable Market & Regulatory Dynamics:– Health and regulatory pressures to moderate calorific intakes continue to increase with a series of government initiatives such

as the sugar tax in Mexico or the “Traffic Light” labelling in the UK.– Mintel data shows adoption by numbers of product continuing to grow at more than 50% a year.

• Consolidation of PureCircle Innovation Strategy:– Reb M and new flavors approved by US regulatory bodies– The Group now has 12 products in market under our proprietary Stevia 3.0 TM portfolio.– Growing use of our proprietary Stevia 3.0 TM blends to formulate great tasting consumer products.

• Organization and Supply Chain Investments– During FY14 in-market application laboratories were opened in Mexico and Malaysia to support LATAM and SEA Markets.– Increased investment in diversified leaf supply at our Kenya and Paraguay operations in anticipation of growth in market

demand.– Supply chain delivered record volumes across a wider product portfolio to a wider range of delivery locations, confirming the

scalable nature of PureCircle business model.– Implementation of a global integrated Enterprise Wide Operational System- JD Edwards– A new Operating Committee reporting to the CEO has been implemented including new senior hires in key areas of Leaf

Development and Supply, Quality Control, Operational Finance and Human Resources.

FY14 Operational Overview: Step Change


15

+58%

70,200

2012

101,045

2014

44,475

2013

+44%

FY14 Topline Sales Analysis

• FY14 sales increased $31m (44%) to $101m. • Average pricing increased 5% in FY14. • Sales to Global Key Accounts grew faster than sales to regional Accounts

PureCircle Volume By Quarter


Stevia 3.0TM Portfolio: Continuous Evolution in FY14

GlycosideBlends

Reb APremium

Blends Reb M*

SG95SG95-20SG95-30

Reb A 97Reb A 99

AlphaAlpha 2DeltaBeta

PureCircle Targeted Solutions = Formulators’ Tool Box

Natural Flavors

NSF-01NSF-02NSF-03NSF-04

Introduced in FY14

* Developed with TCCC

• In FY14 volumes increased 37% led by sales of new ingredients from our Stevia 3.0 TM portfolio. • The Group now has 12 products in market under our proprietary Stevia 3.0 TM portfolio. • Growing use of blends of our proprietary Stevia 3.0 TM portfolio to formulate great tasting consumer products. • December 2013 GRAS approval for Reb M and approval in March 2014 for an increased range of natural flavours.• Further potential in our innovation pipeline in the pipeline for FY15 and subsequent years.


NETHERLANDS

ITALY

ITALY.

CHILE

CANADA CHINA

UK/US

FRANCE

GREECE/CYPRUS ISRAEL

MALAYSIA

COLOMBIAPARAGUAY

USA

CHINA

CHINA

Q2 2014 New Product Launches: Global and Diversified

ROMANIA.

MEXICO

AUSTRALIAINDONESIA

MEXICO

UKPHILIPPINES

ARGENTINA

CARB

ON

ATED

SO

FT D

RIN

KS

JUIC

E BE

VRAG

ES

SYRU

PSDA

IRY

SOY

SAU

CERT

D T

EA

TABL

E TO

P

CERE

AL

WAT

ER

USA


FY14 Step Change: Market Adoption of Stevia by the leading CSD brands in a variety of strategic approaches to market

Reformulation New Launch<3

0% R

educ

tion

30%

-50%

Red

uctio

n>5

0% R

educ

tion

Sugar Moderation for Kids

Replace Artificial SweetenersRedefine Regular Cost SavingsNew Innovation

100%


http://www.google.com/url?sa=i&rct=j&q=sprite+mexico&source=images&cd=&cad=rja&docid=rMksRfaVtJDDiM&tbnid=Sz8D8ZLKB9rc3M:&ved=0CAUQjRw&url=http://creatividad360grados.wordpress.com/2012/07/03/sprite-edicion-especial-mexico-by-grand-chamaco/&ei=HP6cUf-kLuaDywHi84HwAw&bvm=bv.46751780,d.aWc&psig=AFQjCNG9gj40PPmqE-dU4km8URgL-75tFA&ust=1369329561577538

http://www.google.com/url?sa=i&rct=j&q=sprite+mexico&source=images&cd=&cad=rja&docid=rMksRfaVtJDDiM&tbnid=Sz8D8ZLKB9rc3M:&ved=0CAUQjRw&url=http://creatividad360grados.wordpress.com/2012/07/03/sprite-edicion-especial-mexico-by-grand-chamaco/&ei=HP6cUf-kLuaDywHi84HwAw&bvm=bv.46751780,d.aWc&psig=AFQjCNG9gj40PPmqE-dU4km8URgL-75tFA&ust=1369329561577538

http://www.google.com/url?sa=i&rct=j&q=fanta+sabor+naranja&source=images&cd=&cad=rja&docid=bqAOQscSVdzzLM&tbnid=jZlXTRhafsG9TM:&ved=0CAUQjRw&url=http://www.lider.cl/dys/jump/Bebidas-Desechables/Bebida-Fantasia-Sabor-Naranja/PROD_470445&ei=mv6cUZr_CLDKyQHy64CQDQ&bvm=bv.46751780,d.aWc&psig=AFQjCNFnvTblj_ZOZZQcCw6kOjMI5JggFA&ust=1369329684405273

http://www.google.com/url?sa=i&rct=j&q=fanta+sabor+naranja&source=images&cd=&cad=rja&docid=bqAOQscSVdzzLM&tbnid=jZlXTRhafsG9TM:&ved=0CAUQjRw&url=http://www.lider.cl/dys/jump/Bebidas-Desechables/Bebida-Fantasia-Sabor-Naranja/PROD_470445&ei=mv6cUZr_CLDKyQHy64CQDQ&bvm=bv.46751780,d.aWc&psig=AFQjCNFnvTblj_ZOZZQcCw6kOjMI5JggFA&ust=1369329684405273

http://www.google.com/url?sa=i&rct=j&q=fanta+china&source=images&cd=&cad=rja&docid=BMY9Wloq7aePEM&tbnid=18mDNV4tMHM7oM:&ved=0CAUQjRw&url=http://www.canmuseum.com/Detail.aspx?CanID=46146&ei=BAOdUeO1J8SwyQHS14GoBQ&bvm=bv.46751780,d.aWc&psig=AFQjCNFE0c7MM8JKRHpNN-4E7reUSnKPhQ&ust=1369330774959752

http://www.google.com/url?sa=i&rct=j&q=fanta+china&source=images&cd=&cad=rja&docid=BMY9Wloq7aePEM&tbnid=18mDNV4tMHM7oM:&ved=0CAUQjRw&url=http://www.canmuseum.com/Detail.aspx?CanID=46146&ei=BAOdUeO1J8SwyQHS14GoBQ&bvm=bv.46751780,d.aWc&psig=AFQjCNFE0c7MM8JKRHpNN-4E7reUSnKPhQ&ust=1369330774959752

http://www.google.com/url?sa=i&rct=j&q=quatro+colombia+coca+cola&source=images&cd=&cad=rja&docid=GO7kKPWz8ej5nM&tbnid=TjM2j7ux6IYqiM:&ved=0CAUQjRw&url=http://alejandramonroy.com/Quatro-Logo-Redesign&ei=1s5ZUde8KuifyQGDyID4AQ&bvm=bv.44442042,d.aWc&psig=AFQjCNH22HizVG-CAZyjZO9H8Gp6RE1aUA&ust=1364926519081163

http://www.google.com/url?sa=i&rct=j&q=quatro+colombia+coca+cola&source=images&cd=&cad=rja&docid=GO7kKPWz8ej5nM&tbnid=TjM2j7ux6IYqiM:&ved=0CAUQjRw&url=http://alejandramonroy.com/Quatro-Logo-Redesign&ei=1s5ZUde8KuifyQGDyID4AQ&bvm=bv.44442042,d.aWc&psig=AFQjCNH22HizVG-CAZyjZO9H8Gp6RE1aUA&ust=1364926519081163

http://www.cocacola.co.jp/products/lineup/fanta02.html

http://www.cocacola.co.jp/products/lineup/fanta02.html

http://www.gnpd.com/sinatra/gnpd/images/newzoom&id=2035428&pic_num=0&destWidth=400&destHeight=400&origWidth=400&origHeight=400




http://www.google.com/url?sa=i&rct=j&q=schweppes+mineral+water+australia&source=images&cd=&cad=rja&docid=GAVK22AMPFYPhM&tbnid=yofO65v2kpgMAM:&ved=0CAUQjRw&url=http://www.productreview.com.au/p/schweppes-flavoured-mineral-water.html&ei=OwOdUYveCsqWyAGt74HwBw&bvm=bv.46751780,d.aWc&psig=AFQjCNF6nI37BR9KaLaAkIGi5RazlTjWxQ&ust=1369330872696101

http://www.google.com/url?sa=i&rct=j&q=schweppes+mineral+water+australia&source=images&cd=&cad=rja&docid=GAVK22AMPFYPhM&tbnid=yofO65v2kpgMAM:&ved=0CAUQjRw&url=http://www.productreview.com.au/p/schweppes-flavoured-mineral-water.html&ei=OwOdUYveCsqWyAGt74HwBw&bvm=bv.46751780,d.aWc&psig=AFQjCNF6nI37BR9KaLaAkIGi5RazlTjWxQ&ust=1369330872696101

http://www.google.com/url?sa=i&rct=j&q=&esrc=s&source=images&cd=&cad=rja&uact=8&docid=VvOEo-GgwDzyzM&tbnid=wnm5Ajd8tPb58M:&ved=0CAUQjRw&url=http://www.doobybrain.com/2013/08/26/coca-cola-life-naturally-sweetened-sugar-stevia/&ei=SZYxU9LcG8XBqAHh4IGgBA&bvm=bv.63587204,d.aWM&psig=AFQjCNGPloCR0CQ-xDwk7WNHMqNUPuy3Ig&ust=1395845055486392

http://www.google.com/url?sa=i&rct=j&q=&esrc=s&source=images&cd=&cad=rja&uact=8&docid=VvOEo-GgwDzyzM&tbnid=wnm5Ajd8tPb58M:&ved=0CAUQjRw&url=http://www.doobybrain.com/2013/08/26/coca-cola-life-naturally-sweetened-sugar-stevia/&ei=SZYxU9LcG8XBqAHh4IGgBA&bvm=bv.63587204,d.aWM&psig=AFQjCNGPloCR0CQ-xDwk7WNHMqNUPuy3Ig&ust=1395845055486392

Typical Values 100ml (3.5floz) provide

A 200ml (7floz) serving provides

Energy 210kJ (49kcal) 420kJ (100kcal)

Protein trace trace

Carbohydrate 12.3g 24.6g

Sugars 12.3g 24.6g

Fat trace trace

Saturates 0g 0g

Fibre trace trace

Sodium* 0g 0g

A 50% sugar reduction using stevia will yield:Typical values per 100ml per 200ml

serving

Sugars 6.1 g 12.3 g

Moving Customer Cranberry Juice Drink from red to amber

Options “Reduced sugar”“50% less sugar““Stevia leaf extract”

Cost saving 2p / Ltr vs. sugar that’s £20k / Million Litres

UK traffic light case study: Cranberry Juice Drink 1Litre

Health and regulatory pressures to moderate calorific intakes


Growth in new product launches with stevia is accelerating globally across categories beyond beverages

Years are PureCircle FiscalSource: Mintel, 2014

Category #FY14 5 Yr CAGRRTDs 133 101.5%Sugar & Gum Confectionery 111 94.4%Sweet Spreads 53 92.6%Water 97 89.2%Dairy 168 83.8%Bakery 130 79.4%Juice Drinks 208 76.9%Meals & Meal Centers 36 64.4%Carbonated Soft Drinks 132 61.5%Other Beverages 167 59.9%Hot Beverages 103 59.4%Sports & Energy Drinks 60 58.5%Breakfast Cereals 17 53.4%Sauces & Seasonings 63 51.1%Desserts & Ice Cream 61 46.6%Sweeteners & Sugar 161 46.3%Processed Fish, Meat & Egg Products 27 40.1%Fruit & Vegetables 5 38.0%Snacks 396 28.3%Chocolate Confectionery 78 --Baby Food 9 --Alcoholic Beverages 7 --Soup 4 --Savoury Spreads 3 --Side Dishes 2 --Total Launches 2231 54.8%

Categories Ranked by Launch Growth FY09-FY14

251368

493

987

1314

2231

0

500

1000

1500

2000

2500

FY09 FY10 FY11 FY12 FY13 FY14

# la

unch

es

Global Food & Beverage Product Launches With Stevia

5 Year CAGR: +55%


Expansion of Application formulation and technical support

US Lab Expansion: 9/2013China Lab Upgrade: 11/2013

Mexico New Lab: 1/2014

EU Lab Expansion: 1/2014

Malaysia New Lab: 3/2014• Expanded sensory, CSD

capabilities.• Added technologist and senior

scientist

• Expanded processing capabilities.

• Expanded dairy capabilities.• Added two scientists

• Applications manager added

• Application Scientist added

• During FY14 application laboratories were opened in Mexico and Malaysia to support growth in Latin America and South East Asia Markets.

• PureCircle expanded its PureCircle University program, hosting more than 100 PureCircle University programs around the globe for our Key Customers resulting in the accelerated use by customers of proprietary PureCircle Stevia 3.0 TM products and blends.


is working in collaboration with key customers, to tailor advocacy support for significant product launches and reformulations.

www.globalsteviainstitute.com

Through advisory board member led activity, the GSI was able to reach more than 6,000 health

professionals and influencers in FY14


http://www.globalsteviainstitute.com/

Diversification and Scaling Up of Leaf Supply

• Leaf Diversification is key for scaling leaf volume, improve leaf quality, security of supply and avoid leaf cost fluctuations

• We have increased investment across our leaf operations in Africa and South America and in FY15 we expect these regions to significantly contribute on our overall supply

We have a diverse and consistent leaf source across 25,000 individual farmers


New PureCircle Operational Management

A new Operating Committee reporting to the COO has been implemented including new senior hires in key areas of Leaf Development and Supply, Quality Control, Operational Finance and Human Resources.


The Key to PureCircle and Stevia Continuous Success

• Continue supporting our Key Customers in the areas of Ingredient Reputation Management, Application & Regulatory guidance as well as Consumer Insights & trends

• Consolidate Global Diversified Leaf Sourcing with the goal to deliver 50% of requirements from Africa and Latin America in the next 12 months

• Maximize current capacity in order to deliver lower manufacturing costs and improved gross margins

• Expand innovation strategy focusing to deliver good tasting 0 calorie CSDs including propagation of leaf varieties which will increase yields to deliver better tasting Stevia Molecules on a large scale



4. Outlook

by Magomet Malsagov, CEO

Outlook (1)

• Our FY14 results provide strong evidence of the scalability of our business model with highersales volumes leading to strong improvements in gross margin, operating profit and EBITDA.

• Further improvements in profitability should arise as volumes increase.

• Market adoption of PureCircle Stevia is accelerating, particularly in the important CarbonatedSoft Drink category.

• The scale and breadth of market adoption across more categories and more countries isstrong evidence of stevia becoming a mass volume mainstream ingredient.

• Blends of our proprietary products are accelerating.

• Coupled with our strong innovation pipeline, this provides us with further confidence in thefuture of our business.


Outlook (2)

• As highlighted in this presentation, the Company is in growth phase with continuedinvestment in market development, product innovation, supply chain and organization. Weexpect this to continue in FY15.

• We have renewed and extended for 5 years our principal debt facilities and are sufficientlyfunded for our current growth plans.

• Recent CSD launches in major markets are significant and are expected to have growingimpact from CY 2015.

• The seasonality seen in our business in prior years is expected to continue with sales beingH2 weighted.

• Our guidance for H1 FY15 is for sales to be in the range $40 to $45m.



5. Questions

PureCircle Limited : FY14– Audited Full Year ResultsAnalyst Call - 10 September 2014


PureCircle Limited : FY14–Audited Full Year Results · 10/09/2014 · - FY14 was an important...

Documents

Transcript of PureCircle Limited : FY14–Audited Full Year Results · 10/09/2014 · - FY14 was an important...